Clinical Social Workers in Redmond, WA Accepting Medicare

42 Clinical Social Workers found. Showing 41 - 42

Joanne Nguyen, MSW, LSWAIC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15600 Redmond Way Ste 202, Redmond, WA 98052 Phone: 425-224-5913

Madhulika Sarupria, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16225 Ne 87th St, Redmond, WA 98052 Phone: 425-653-4960    Fax: 425-653-4961

News Archive

Flat polyps may explain colorectal cancer screening discrepancy

Poor ability to detect sessile serrated polyps may explain why endoscopy is more effective at reducing cancer in the distal than the proximal colon, US researchers have discovered.

Study indicates how drug efficacy can be increased by manipulating the signalling mechanism

Researchers believe they have found a way to change the action of 60 percent of currently available medications, in some cases making them many times more effective, according to an article published in the April 21 edition of the journal Science. The discovery has the potential to improve treatments for diseases including heart disease, cancer, diabetes, depression and arthritis. The study describes a new way to manipulate perhaps the most important signaling mechanism in human cells: G-protein coupled receptors (GPCRs).

Additional data from Sanofi's quadrivalent inactivated influenza vaccine study

Sanofi Pasteur, the vaccines division of Sanofi, announced today the results of a new study evaluating the immunogenicity and safety of an investigational quadrivalent inactivated influenza vaccine (QIV) among adults 65 years of age and older.

Positive interim results from Fraunhofer USA CMB's HAC1 influenza vaccine Phase 1 trial

Fraunhofer USA Center for Molecular Biotechnology, a not-for-profit, Delaware-based organization focused on developing a proprietary plant-based protein production platform and its applications in vaccine and therapeutic fields, today announced positive interim results from the first human trial of plant-produced H1N1 influenza vaccine that began on September 13, 2010.

BioVex's Phase 3 melanoma study amended to include first line patients

BioVex Inc, a company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has agreed that BioVex's ongoing OPTiM clinical study in unresectable Stage IIIb-IV melanoma be amended to include untreated (i.e., first line) patients as well as previously treated patients as defined in the original protocol.

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3(current)